Literature DB >> 22405175

Portal vein thrombosis in inflammatory bowel diseases: a single-center case series.

Giovanni Maconi1, Elena Bolzacchini, Alessandra Dell'Era, Umberto Russo, Sandro Ardizzone, Roberto de Franchis.   

Abstract

BACKGROUND AND METHODS: Portal vein thrombosis (PVT) has been reported as a complication of IBD in some case reports. We describe the presentation, diagnostic approaches, underlying risks factors and clinical outcome of 8 IBD patients with PVT. CASE-SERIES: The patients presented with partial PVT (4 patients) or portal cavernoma. Five patients had undergone surgery. In 2 patients portal biliopathy was diagnosed after detection of PVT. In 4 patients, the diagnosis of PVT was made while IBD was in remission. Five patients showed at least one risk factor for hypercoagulability: lupus anti-coagulant (one patient), increased von Willebrand factor (2 patients) or homocysteine levels (4 patients). Four patients received anticoagulant therapy for 6 months. None experienced other thrombotic events during a median of 5 years (range 2-8 years).
CONCLUSION: PVT is a potential complication of IBD, usually associated with acquired or inherited risks factors for hypercoagulability and with a benign outcome. Copyright Â
© 2011 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22405175     DOI: 10.1016/j.crohns.2011.10.003

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  9 in total

Review 1.  Nontraumatic splenic emergencies: cross-sectional imaging findings and triage.

Authors:  Massimo Tonolini; Roberto Bianco
Journal:  Emerg Radiol       Date:  2013-01-15

Review 2.  Glucose intolerance and diabetes mellitus in ulcerative colitis: pathogenetic and therapeutic implications.

Authors:  Giovanni Maconi; Federica Furfaro; Roberta Sciurti; Cristina Bezzio; Sandro Ardizzone; Roberto de Franchis
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

3.  Non-surgical porto-mesenteric vein thrombosis is associated with worse long-term outcomes in inflammatory bowel diseases.

Authors:  Zubin Arora; Xianrui Wu; Udayakumar Navaneethan; Bo Shen
Journal:  Gastroenterol Rep (Oxf)       Date:  2015-04-28

Review 4.  Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review.

Authors:  Fotios S Fousekis; Vasileios I Theopistos; Konstantinos H Katsanos; Epameinondas V Tsianos; Dimitrios K Christodoulou
Journal:  Gastroenterology Res       Date:  2018-04-07

Review 5.  Liver involvement in inflammatory bowel disease: What should the clinician know?

Authors:  Giuseppe Losurdo; Irene Vita Brescia; Chiara Lillo; Martino Mezzapesa; Michele Barone; Mariabeatrice Principi; Enzo Ierardi; Alfredo Di Leo; Maria Rendina
Journal:  World J Hepatol       Date:  2021-11-27

6.  Circulating exosomal miR-21 mediates HUVEC proliferation and migration through PTEN/PI3K/AKT in Crohn's disease.

Authors:  Xiaoran Xie; Peng Qu; Hao Wu; Peng Liu; Ju Luo; Jingshu Chi; Xiaoming Liu; Xiong Chen; Canxia Xu
Journal:  Ann Transl Med       Date:  2022-03

7.  miR-21 antagonist alleviates colitis and angiogenesis via the PTEN/PI3K/AKT pathway in colitis mice induced by TNBS.

Authors:  Xiaoran Xie; Peng Liu; Hao Wu; Huan Li; Yu Tang; Xiong Chen; Canxia Xu; Xiaoming Liu; Guoyu Dai
Journal:  Ann Transl Med       Date:  2022-04

8.  The Natural History, Treatments, and Outcomes of Portal Vein Thrombosis in Patients With Inflammatory Bowel Disease.

Authors:  Leonard Naymagon; Douglas Tremblay; Nicole Zubizarreta; Erin Moshier; Steven Naymagon; John Mascarenhas; Thomas Schiano
Journal:  Inflamm Bowel Dis       Date:  2021-01-19       Impact factor: 5.325

9.  The role of portal vein thrombosis in the clinical course of inflammatory bowel diseases: report on three cases and review of the literature.

Authors:  Emanuele Sinagra; Emma Aragona; Claudia Romano; Simonetta Maisano; Ambrogio Orlando; Roberto Virdone; Lorenzo Tesè; Irene Modesto; Valeria Criscuoli; Mario Cottone
Journal:  Gastroenterol Res Pract       Date:  2012-10-11       Impact factor: 2.260

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.